Simul-seq: Combined DNA and RNA sequencing for whole-genome and transcriptome profiling

Nature Methods

Volumn 13, Issue 11, 2016, Pages 953-958

  Reuter, Jason A ^a   Spacek, Damek V ^a   Pai, Reetesh K ^a,b   Snyder, Michael P ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; KINESIN; MINICHROMOSOME MAINTENANCE PROTEIN 3; PROTEIN; PROTEIN CSTF1; PROTEIN EWSR1; PROTEIN FAT1; PROTEIN H2AFY; PROTEIN KIF3B; PROTEIN LRP1; PROTEIN MADD; PROTEIN MCM3AP; PROTEIN P53; PROTEIN ZNF615; TRANSCRIPTOME; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; UNTRANSLATED RNA; DNA; KIF3B PROTEIN, HUMAN; MESSENGER RNA; TN5 TRANSPOSASE; TRANSPOSASE;

ARTICLE; CANCER THERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; DNA SEQUENCE; ESOPHAGEAL ADENOCARCINOMA; GENE EXPRESSION; GENE FREQUENCY; GENE MUTATION; HIGH THROUGHPUT SEQUENCING; HOMOZYGOSITY; HUMAN; LASER CAPTURE MICRODISSECTION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; RNA SEQUENCE; TUMOR GENE; ESOPHAGUS TUMOR; GENE EXPRESSION PROFILING; GENE LIBRARY; GENETICS; HUMAN GENOME; MALE; MUTATION; PROCEDURES; SEQUENCE ANALYSIS;

DNA; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION PROFILING; GENE LIBRARY; GENOME, HUMAN; HUMANS; KINESIN; MALE; MUTATION; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; SEQUENCE ANALYSIS, RNA; TRANSCRIPTOME; TRANSPOSASES;

EID: 84990986018     PISSN: 15487091     EISSN: 15487105     Source Type: Journal    
DOI: 10.1038/nmeth.4028     Document Type: Article

References (64)

1. Shah, S.P. et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature 486, 395-399 (2012).
2. Grubert, F. et al. Genetic control of chromatin states in humans involves local and distal chromosomal interactions. Cell 162, 1051-1065 (2015).
3. Stranger, B.E. et al. Population genomics of human gene expression. Nat. Genet. 39, 1217-1224 (2007).
4. Ongen, H. et al. Putative cis-regulatory drivers in colorectal cancer. Nature 512, 87-90 (2014).
5. Li, J.B. et al. Genome-wide identification of human RNA editing sites by parallel DNA capturing and sequencing. Science 324, 1210-1213 (2009).
6. Tuch, B.B. et al. Tumor transcriptome sequencing reveals allelic expression imbalances associated with copy number alterations. PLoS One 5, e9317 (2010).
7. Su, A.I. et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA 101, 6062-6067 (2004).
8. Lappalainen, T. et al. Transcriptome and genome sequencing uncovers functional variation in humans. Nature 501, 506-511 (2013).
9. Macaulay, I.C. et al. G&T-seq: parallel sequencing of single-cell genomes and transcriptomes. Nat. Methods 12, 519-522 (2015).
10. Dey, S.S., Kester, L., Spanjaard, B., & Van, A. Integrated genome and transcriptome sequencing from the same cell. Nat. Biotechnol. 33, 1-19 (2015).
11. Lam, H.Y.K. et al. Performance comparison of whole-genome sequencing platforms. Nat. Biotechnol. 30, 78-82 (2011).
12. Adey, A. et al. Rapid, low-input, low-bias construction of shotgun fragment libraries by high-density in vitro transposition. Genome Biol. 11, R119 (2010).
13. Baker, S.C. et al. The External RNA Controls Consortium: a progress report. Nat. Methods 2, 731-734 (2005).
14. Lawrence, M.S. et al. Discovery and saturation analysis of cancer genes across 21 tumour types. Nature 505, 495-501 (2014).
15. Weinstein, J.N. et al. Cancer Genome Atlas Research Network. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507, 315-322 (2014).
16. Zhao, M., Kim, P., Mitra, R., Zhao, J., & Zhao, Z. TSGene 2.0: an updated literature-based knowledgebase for tumor suppressor genes. Nucleic Acids Res. 4, D1023-D1031 (2015).
17. Adzhubei, I.A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248-249 (2010).
18. Kumar, P., Henikoff, S., & Ng, P.C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4, 1073-1081 (2009).
19. Yadav, M. et al. Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing. Nature 515, 572-576 (2014).
20. Robbins, P.F. et al. Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells. Nat. Med. 19, 747-752 (2013).
21. Schumacher, T.N., & Schreiber, R.D. Neoantigens in cancer immunotherapy. Science 348, 69-74 (2015).
22. Futreal, P.A. et al. A census of human cancer genes. Nat. Rev. Cancer 4, 177-183 (2004).
23. Joerger, A.C., Ang, H.C., & Fersht, A.R. Structural basis for understanding oncogenic p53 mutations and designing rescue drugs. Proc. Natl. Acad. Sci. USA 103, 15056-15061 (2006).
24. Bullock, A.N., Henckel, J., & Fersht, A.R. Quantitative analysis of residual folding and DNA binding in mutant p53 core domain: definition of mutant states for rescue in cancer therapy. Oncogene 19, 1245-1256 (2000).
25. Gautschi, O. et al. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients. Lung Cancer 51, 303-311 (2006).
26. Absenger, G. et al. The cyclin D1 (CCND1) rs9344 G>A polymorphism predicts clinical outcome in colon cancer patients treated with adjuvant 5-FU-based chemotherapy. Pharmacogenomics J. 14, 130-134 (2014).
27. Gonçalves, A. et al. A polymorphism of EGFR extracellular domain is associated with progression free-survival in metastatic colorectal cancer patients receiving cetuximab-based treatment. BMC Cancer 8, 169 (2008).
28. Hsieh, Y.Y., Tzeng, C.H., Chen, M.H., Chen, P.M., & Wang, W.S. Epidermal growth factor receptor R521K polymorphism shows favorable outcomes in KRAS wild-Type colorectal cancer patients treated with cetuximab-based chemotherapy. Cancer Sci. 103, 791-796 (2012).
29. Yu, Y., & Feng, Y.-M. The role of kinesin family proteins in tumorigenesis and progression: potential biomarkers and molecular targets for cancer therapy. Cancer 116, 5150-5160 (2010).
30. Jimbo, T. et al. Identification of a link between the tumour suppressor APC and the kinesin superfamily. Nat. Cell Biol. 4, 323-327 (2002).
31. Woehlke, G. et al. Microtubule interaction site of the kinesin motor. Cell 90, 207-216 (1997).
32. Dey, S.S., Kester, L., Spanjaard, B., Bienko, M., & van Oudenaarden, A. Integrated genome and transcriptome sequencing of the same cell. Nat. Biotechnol. 33, 285-289 (2015).
33. Macaulay, I.C. et al. G&T-seq: parallel sequencing of single-cell genomes and transcriptomes. Nat. Methods 12, 519-522 (2015).
34. Adiconis, X. et al. Comparative analysis of RNA sequencing methods for degraded or low-input samples. Nat. Methods 10, 623-629 (2013).
35. Zhao, W. et al. Comparison of RNA-Seq by poly (A) capture, ribosomal RNA depletion, and DNA microarray for expression profiling. BMC Genomics 15, 419 (2014).
36. Nones, K. et al. Genomic catastrophes frequently arise in esophageal adenocarcinoma and drive tumorigenesis. Nat. Commun. 5, 5224 (2014).
37. Agrawal, N. et al. Comparative genomic analysis of esophageal adenocarcinoma and squamous cell carcinoma. Cancer Discov. 2, 899-905 (2012).
38. Dulak, A.M. et al. Exome and whole-genome sequencing of esophageal adenocarcinoma identifies recurrent driver events and mutational complexity. Nat. Genet. 45, 478-486 (2013).
39. Haraguchi, K., Hayashi, T., Jimbo, T., Yamamoto, T., & Akiyama, T. Role of the kinesin-2 family protein, KIF3, during mitosis. J. Biol. Chem. 281, 4094-4099 (2006).
40. Liu, X. et al. Small molecule induced reactivation of mutant p53 in cancer cells. Nucleic Acids Res. 41, 6034-6044 (2013).
41. Stachler, M.D. et al. Paired exome analysis of Barrett's esophagus and adenocarcinoma. Nat. Genet. 47, 1047-1055 (2015).
42. Moriai, T., Kobrin, M.S., Hope, C., Speck, L., & Korc, M. A variant epidermal growth factor receptor exhibits altered type alpha transforming growth factor binding and transmembrane signaling. Proc. Natl. Acad. Sci. USA 91, 10217-10221 (1994).
43. Zhang, W. et al. Cyclin D1 and epidermal growth factor polymorphisms associated with survival in patients with advanced colorectal cancer treated with Cetuximab. Pharmacogenet. Genomics 16, 475-483 (2006).
44. Martin, M. Cutadapt removes adapter sequences from high-Throughput sequencing reads. EMBnet.journal 17, 10-12 (2011).
45. Li, H., & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760 (2009).
46. DePristo, M.A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491-498 (2011).
47. Langmead, B., & Salzberg, S.L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357-359 (2012).
48. Trapnell, C. et al. Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks. Nat. Protoc. 7, 562-578 (2012).
49. Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28, 511-515 (2010).
50. Danecek, P. et al. The variant call format and VCFtools. Bioinformatics 27, 2156-2158 (2011).
51. Wang, L., Wang, S., & Li, W. RSeQC: quality control of RNA-seq experiments. Bioinformatics 28, 2184-2185 (2012).
52. Quinlan, A.R., & Hall, I.M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841-842 (2010).
53. Liao, Y., Smyth, G.K., & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923-930 (2014).
54. Roth, A. et al. JointSNVMix: a probabilistic model for accurate detection of somatic mutations in normal/tumour paired next-generation sequencing data. Bioinformatics 28, 907-913 (2012).
55. Cibulskis, K. et al. Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples. Nat. Biotechnol. 31, 213-219 (2013).
56. Larson, D.E. et al. SomaticSniper: identification of somatic point mutations in whole genome sequencing data. Bioinformatics 28, 311-317 (2012).
57. Koboldt, D.C. et al. VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing. Genome Res. 22, 568-576 (2012).
58. Wang, J. et al. CREST maps somatic structural variation in cancer genomes with base-pair resolution. Nat. Methods 8, 652-654 (2011).
59. Zhang, J. et al. INTEGRATE: gene fusion discovery using whole genome and transcriptome data. Genome Res. 26, 108-118 (2016).
60. Krzywinski, M. et al. Circos: an information aesthetic for comparative genomics. Genome Res. 19, 1639-1645 (2009).
61. Cingolani, P. et al. Using Drosophila melanogaster as a model for genotoxic chemical mutational studies with a new program, SnpSift. Front. Genet. 3, 35 (2012).
62. Romanel, A., Lago, S., Prandi, D., Sboner, A., & Demichelis, F. ASEQ: fast allele-specific studies from next-generation sequencing data. BMC Med. Genomics 8, 9 (2015).
63. Li, H. et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 25, 2078-2079 (2009).
64. Stock, M.F., & Hackney, D.D. Expression of kinesin in Escherichia coli. Methods Mol. Biol. 164, 43-48 (2001).